Thu, Nov 27, 2014, 5:07 AM EST - U.S. Markets closed for Thanksgiving Day

Recent

% | $
Quotes you view appear here for quick access.

Exelixis, Inc. Message Board

  • enabeler enabeler May 2, 2013 2:18 PM Flag

    No more excuses or theories.

    Management seems to care less and even worse they are not committed enough to put their own money into it.
    Without a doubt, perhaps the most disappointing stock I've ever been in. I've made money trading it but frankly I've stuck around for the science and the big payoff for the patients. I no longer have any theories or excuses, I just believe.

    Sentiment: Strong Buy

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • Problem #1 is always going to be that they get paid no matter how the stock performs. Until we can get executive compensation aligned with equity performance, much ado about nothing. It's such a shame because Cometriq is a heck of a drug that just isn't getting to patients fast enough and the FDA keeps reminding of the old Indian adage "White men speak with false tongue" (or 2 tongues).

    • $$$$
      "I no longer have any theories or excuses, I just believe.."

      Just for the record, I believe too....
      I believe I'll have another brew.
      Sometimes EXEL actually pays the bar tab...
      GLTA

 
EXEL
1.76+0.040(+2.33%)Nov 26 4:00 PMEST

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.